Loading…
Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 gen...
Saved in:
Published in: | Journal of gastroenterology 2009-09, Vol.44 (9), p.952-963 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093 |
---|---|
cites | cdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093 |
container_end_page | 963 |
container_issue | 9 |
container_start_page | 952 |
container_title | Journal of gastroenterology |
container_volume | 44 |
creator | Okanoue, Takeshi Itoh, Yoshito Hashimoto, Hiroaki Yasui, Kohichiroh Minami, Masahito Takehara, Tetsuo Tanaka, Eiji Onji, Morikazu Toyota, Joji Chayama, Kazuaki Yoshioka, Kentaro Izumi, Namiki Akuta, Norio Kumada, Hiromitsu |
description | Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender. |
doi_str_mv | 10.1007/s00535-009-0087-x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21084030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1862216151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROO3oA7hR4sJdKRRQP-4mHX8zUZNx1uQ2XHqYVBUlUJPpV_CppVOdTOLCBSE5fOdw4RDykrN3nLH2fWJMCVUx1pfVtdX9I7Lhsiiqr-vHZMN6KSvOW3lGnqV0yxgXTHVPyRnvFW-Zajfkz8-I1pvs75DewbBgosFRGP0UKBhvacLfC05m1fMNUhMiUpgs_X6lLmjEvQ9Ton4qWknxEYYjFmE-UBcivcEZss8-0e0HCvQbzDBhQjouQ_aVwSljpCkv9vCcPHEwJHxx2s_J9aePv7Zfqssfn79uLy4ro6TMVWOc4KIG5hClkSCafrdTxoIwaGXfNY2ru51itmNoFRppuQMrQDjZM8F6cU7errlzDOVtKevRJ4PDUAYLS9I1Z50sZAHf_APehiVOZbbCtLx8sqwLxFfIxJBSRKfn6EeIB82ZPrak15Z0aUkfW9L3xfPqFLzsRrQPjlMtBahXIJWjaY_x4eb_pb5eTQ6Chn30SV9f1cfOedPxpm_FXyYvqCU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217159242</pqid></control><display><type>article</type><title>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</title><source>Springer Nature</source><creator>Okanoue, Takeshi ; Itoh, Yoshito ; Hashimoto, Hiroaki ; Yasui, Kohichiroh ; Minami, Masahito ; Takehara, Tetsuo ; Tanaka, Eiji ; Onji, Morikazu ; Toyota, Joji ; Chayama, Kazuaki ; Yoshioka, Kentaro ; Izumi, Namiki ; Akuta, Norio ; Kumada, Hiromitsu</creator><creatorcontrib>Okanoue, Takeshi ; Itoh, Yoshito ; Hashimoto, Hiroaki ; Yasui, Kohichiroh ; Minami, Masahito ; Takehara, Tetsuo ; Tanaka, Eiji ; Onji, Morikazu ; Toyota, Joji ; Chayama, Kazuaki ; Yoshioka, Kentaro ; Izumi, Namiki ; Akuta, Norio ; Kumada, Hiromitsu</creatorcontrib><description>Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.</description><identifier>ISSN: 0944-1174</identifier><identifier>EISSN: 1435-5922</identifier><identifier>DOI: 10.1007/s00535-009-0087-x</identifier><identifier>PMID: 19517057</identifier><language>eng</language><publisher>Japan: Japan : Springer Japan</publisher><subject>Abdominal Surgery ; Adolescent ; Adult ; Aged ; Amino Acid Sequence ; Amino Acid Substitution ; Antiviral Agents - pharmacology ; Biliary Tract ; Colorectal Surgery ; Drug Resistance, Viral ; Drug Therapy, Combination ; Female ; Gastroenterology ; Genotype ; Hepacivirus - drug effects ; Hepacivirus - genetics ; Hepatitis C virus ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - genetics ; Hepatology ; Humans ; Interferon alpha-2 ; Interferon-alpha - pharmacology ; Japan ; Male ; Medication Adherence ; Medicine ; Medicine & Public Health ; Middle Aged ; Multivariate Analysis ; Mutation ; Original Article—Liver ; Pancreas ; Polyethylene Glycols - pharmacology ; Recombinant Proteins ; Retrospective Studies ; Ribavirin - pharmacology ; Risk Factors ; Sex Factors ; Surgical Oncology ; Viral Load ; Viral Nonstructural Proteins - genetics ; Young Adult</subject><ispartof>Journal of gastroenterology, 2009-09, Vol.44 (9), p.952-963</ispartof><rights>Springer 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</citedby><cites>FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19517057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okanoue, Takeshi</creatorcontrib><creatorcontrib>Itoh, Yoshito</creatorcontrib><creatorcontrib>Hashimoto, Hiroaki</creatorcontrib><creatorcontrib>Yasui, Kohichiroh</creatorcontrib><creatorcontrib>Minami, Masahito</creatorcontrib><creatorcontrib>Takehara, Tetsuo</creatorcontrib><creatorcontrib>Tanaka, Eiji</creatorcontrib><creatorcontrib>Onji, Morikazu</creatorcontrib><creatorcontrib>Toyota, Joji</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><creatorcontrib>Yoshioka, Kentaro</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><creatorcontrib>Akuta, Norio</creatorcontrib><creatorcontrib>Kumada, Hiromitsu</creatorcontrib><title>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</title><title>Journal of gastroenterology</title><addtitle>J Gastroenterol</addtitle><addtitle>J Gastroenterol</addtitle><description>Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.</description><subject>Abdominal Surgery</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Amino Acid Sequence</subject><subject>Amino Acid Substitution</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biliary Tract</subject><subject>Colorectal Surgery</subject><subject>Drug Resistance, Viral</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Genotype</subject><subject>Hepacivirus - drug effects</subject><subject>Hepacivirus - genetics</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - genetics</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Interferon alpha-2</subject><subject>Interferon-alpha - pharmacology</subject><subject>Japan</subject><subject>Male</subject><subject>Medication Adherence</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Mutation</subject><subject>Original Article—Liver</subject><subject>Pancreas</subject><subject>Polyethylene Glycols - pharmacology</subject><subject>Recombinant Proteins</subject><subject>Retrospective Studies</subject><subject>Ribavirin - pharmacology</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Surgical Oncology</subject><subject>Viral Load</subject><subject>Viral Nonstructural Proteins - genetics</subject><subject>Young Adult</subject><issn>0944-1174</issn><issn>1435-5922</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kc2OFCEUhYnROO3oA7hR4sJdKRRQP-4mHX8zUZNx1uQ2XHqYVBUlUJPpV_CppVOdTOLCBSE5fOdw4RDykrN3nLH2fWJMCVUx1pfVtdX9I7Lhsiiqr-vHZMN6KSvOW3lGnqV0yxgXTHVPyRnvFW-Zajfkz8-I1pvs75DewbBgosFRGP0UKBhvacLfC05m1fMNUhMiUpgs_X6lLmjEvQ9Ton4qWknxEYYjFmE-UBcivcEZss8-0e0HCvQbzDBhQjouQ_aVwSljpCkv9vCcPHEwJHxx2s_J9aePv7Zfqssfn79uLy4ro6TMVWOc4KIG5hClkSCafrdTxoIwaGXfNY2ru51itmNoFRppuQMrQDjZM8F6cU7errlzDOVtKevRJ4PDUAYLS9I1Z50sZAHf_APehiVOZbbCtLx8sqwLxFfIxJBSRKfn6EeIB82ZPrak15Z0aUkfW9L3xfPqFLzsRrQPjlMtBahXIJWjaY_x4eb_pb5eTQ6Chn30SV9f1cfOedPxpm_FXyYvqCU</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Okanoue, Takeshi</creator><creator>Itoh, Yoshito</creator><creator>Hashimoto, Hiroaki</creator><creator>Yasui, Kohichiroh</creator><creator>Minami, Masahito</creator><creator>Takehara, Tetsuo</creator><creator>Tanaka, Eiji</creator><creator>Onji, Morikazu</creator><creator>Toyota, Joji</creator><creator>Chayama, Kazuaki</creator><creator>Yoshioka, Kentaro</creator><creator>Izumi, Namiki</creator><creator>Akuta, Norio</creator><creator>Kumada, Hiromitsu</creator><general>Japan : Springer Japan</general><general>Springer Japan</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090901</creationdate><title>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</title><author>Okanoue, Takeshi ; Itoh, Yoshito ; Hashimoto, Hiroaki ; Yasui, Kohichiroh ; Minami, Masahito ; Takehara, Tetsuo ; Tanaka, Eiji ; Onji, Morikazu ; Toyota, Joji ; Chayama, Kazuaki ; Yoshioka, Kentaro ; Izumi, Namiki ; Akuta, Norio ; Kumada, Hiromitsu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Abdominal Surgery</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Amino Acid Sequence</topic><topic>Amino Acid Substitution</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biliary Tract</topic><topic>Colorectal Surgery</topic><topic>Drug Resistance, Viral</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Genotype</topic><topic>Hepacivirus - drug effects</topic><topic>Hepacivirus - genetics</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - genetics</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Interferon alpha-2</topic><topic>Interferon-alpha - pharmacology</topic><topic>Japan</topic><topic>Male</topic><topic>Medication Adherence</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Mutation</topic><topic>Original Article—Liver</topic><topic>Pancreas</topic><topic>Polyethylene Glycols - pharmacology</topic><topic>Recombinant Proteins</topic><topic>Retrospective Studies</topic><topic>Ribavirin - pharmacology</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Surgical Oncology</topic><topic>Viral Load</topic><topic>Viral Nonstructural Proteins - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okanoue, Takeshi</creatorcontrib><creatorcontrib>Itoh, Yoshito</creatorcontrib><creatorcontrib>Hashimoto, Hiroaki</creatorcontrib><creatorcontrib>Yasui, Kohichiroh</creatorcontrib><creatorcontrib>Minami, Masahito</creatorcontrib><creatorcontrib>Takehara, Tetsuo</creatorcontrib><creatorcontrib>Tanaka, Eiji</creatorcontrib><creatorcontrib>Onji, Morikazu</creatorcontrib><creatorcontrib>Toyota, Joji</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><creatorcontrib>Yoshioka, Kentaro</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><creatorcontrib>Akuta, Norio</creatorcontrib><creatorcontrib>Kumada, Hiromitsu</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okanoue, Takeshi</au><au>Itoh, Yoshito</au><au>Hashimoto, Hiroaki</au><au>Yasui, Kohichiroh</au><au>Minami, Masahito</au><au>Takehara, Tetsuo</au><au>Tanaka, Eiji</au><au>Onji, Morikazu</au><au>Toyota, Joji</au><au>Chayama, Kazuaki</au><au>Yoshioka, Kentaro</au><au>Izumi, Namiki</au><au>Akuta, Norio</au><au>Kumada, Hiromitsu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study</atitle><jtitle>Journal of gastroenterology</jtitle><stitle>J Gastroenterol</stitle><addtitle>J Gastroenterol</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>44</volume><issue>9</issue><spage>952</spage><epage>963</epage><pages>952-963</pages><issn>0944-1174</issn><eissn>1435-5922</eissn><abstract>Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially older and female patients. Methods To elucidate the factors affecting early and sustained viral responses (EVR and SVR), 409 genotype 1b patients CHC with high viral loads who had received 48 weeks of PEG-IFN/RBV therapy were enrolled. The amino acid (aa) sequences of the HCV core at positions 70 and 91 and of the interferon sensitivity determining region (ISDR) were analyzed. Host factors, viral factors, and treatment-related factors were subjected to multivariate analysis. Results Male gender, low HCV RNA load, high platelet count, two or more aa mutations of ISDR, and wild type of core aa 70 were independent predictive factors for SVR. In patients with over 80% adherences to both PEG-IFN and RBV, male gender, mild fibrosis stage, and wild type of core aa 70 were independent predictors for SVR. Conclusions Independent predictive factors for SVR were: no aa substitution at core aa 70, two or more aa mutations in the ISDR, low viral load, high values of platelet count, mild liver fibrosis and male gender.</abstract><cop>Japan</cop><pub>Japan : Springer Japan</pub><pmid>19517057</pmid><doi>10.1007/s00535-009-0087-x</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0944-1174 |
ispartof | Journal of gastroenterology, 2009-09, Vol.44 (9), p.952-963 |
issn | 0944-1174 1435-5922 |
language | eng |
recordid | cdi_proquest_miscellaneous_21084030 |
source | Springer Nature |
subjects | Abdominal Surgery Adolescent Adult Aged Amino Acid Sequence Amino Acid Substitution Antiviral Agents - pharmacology Biliary Tract Colorectal Surgery Drug Resistance, Viral Drug Therapy, Combination Female Gastroenterology Genotype Hepacivirus - drug effects Hepacivirus - genetics Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - genetics Hepatology Humans Interferon alpha-2 Interferon-alpha - pharmacology Japan Male Medication Adherence Medicine Medicine & Public Health Middle Aged Multivariate Analysis Mutation Original Article—Liver Pancreas Polyethylene Glycols - pharmacology Recombinant Proteins Retrospective Studies Ribavirin - pharmacology Risk Factors Sex Factors Surgical Oncology Viral Load Viral Nonstructural Proteins - genetics Young Adult |
title | Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20values%20of%20amino%20acid%20sequences%20of%20the%20core%20and%20NS5A%20regions%20in%20antiviral%20therapy%20for%20hepatitis%20C:%20a%20Japanese%20multi-center%20study&rft.jtitle=Journal%20of%20gastroenterology&rft.au=Okanoue,%20Takeshi&rft.date=2009-09-01&rft.volume=44&rft.issue=9&rft.spage=952&rft.epage=963&rft.pages=952-963&rft.issn=0944-1174&rft.eissn=1435-5922&rft_id=info:doi/10.1007/s00535-009-0087-x&rft_dat=%3Cproquest_cross%3E1862216151%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c544t-6cf3132a0fee4c4a369bb5cda3ced49866f28b50d80ed5ec4d1fad3a3f4903093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217159242&rft_id=info:pmid/19517057&rfr_iscdi=true |